Cangrelor - a champion lost in translation?
暂无分享,去创建一个
[1] Deepak L. Bhatt,et al. Intravenous platelet blockade with cangrelor during PCI. , 2009, The New England journal of medicine.
[2] Gregg W Stone,et al. Platelet inhibition with cangrelor in patients undergoing PCI. , 2009, The New England journal of medicine.
[3] A. Schömig. Ticagrelor--is there need for a new player in the antiplatelet-therapy field? , 2009, The New England journal of medicine.
[4] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[5] J. Ware,et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. , 2009, European heart journal.
[6] A. Kastrati,et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.
[7] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[8] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.
[9] R. Wilcox,et al. Open Multicentre Study of the P 2T Receptor Antagonist AR-C69931MX Assessing Safety, Tolerability and Activity in Patients with Acute Coronary Syndromes , 2001, Thrombosis and Haemostasis.